Your shopping cart is empty

Subscriber login

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

Check out our free and informative ezines and sign up now

Home > Newsletters > Drug GMP Report > Lax Investigations Into Discrepancies Lands A&Z Pharmaceutical a Form 483

Drug GMP Report

July 2012

Lax Investigations Into Discrepancies Lands A&Z Pharmaceutical a Form 483

A&Z Pharmaceutical failed to adequately investigate unexplained discrepancies in drug products tied to compression-related troubles at the company’s Deer Park, N.Y., plant, a Form 483 states.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Novartis 483 Highlights Rocky Remediation at Nebraska Plant Concerns with Contract Manufacturer Draw Complete Response for Allergan’s Levadex FDA Warning Letter(s)Re-inspection of Hospira’s Rocky Mount Plant Prompts Fresh Form 483

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.